Liposomal Polyethyleneglycol and Polyethyleneglycol-Peptide Combinations for Active Targeting to Liver In Vivo

REFERENCES

• Abraham S. A., Waterhouse D. N., Mayer L. D., Cullis P. R., Madden T. D., Bally M. B. The liposomal formulation of doxorubicin. Methods Enzymol. 2005; 391: 71–97
   PubMed Web of Science ®Google Scholar
• Allen T. M., Martin F. J. Advantages of liposomal delivery systems for anthracyclines. Semin. Oncol. 2004; 31: 5–15
   PubMed Web of Science ®Google Scholar
• Ancsin J. B., Kisilevsky R. A. Binding site for highly sulfated heparan sulfate is identified in the N terminus of the circumsporozoite protein: Significance for malarial sporozoite attachment to hepatocytes. J. Biol. Chem. 2004; 279: 21824–21832
   PubMed Web of Science ®Google Scholar
• Barratt G. Colloidal drug carriers: Achievements and perspectives. Cell. Mol. Life Sci. 2003; 60: 21–37
   PubMed Web of Science ®Google Scholar
• Beavis R. C., Chaudhary T., Chait B. Alpha-cyano-4-hydroxycinnamic acid as a matrix for matrix-assisted laser desorption mass-spectrometry. Org. Mass Spectrom. 1992; 27: 156–158
   Google Scholar
• Bligh E. G., Dyer W. J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 1959; 37: 911–917
   PubMedGoogle Scholar
• Cevc G. Phospholipids Handbook. Marcel Dekker Inc., New York 1993; 946
   Google Scholar
• Charrois G. J. R., Allen T. M. Drug release rate influences the pharmacokinetics, biodistribution, therapeutic activity, and toxicity of pegylated liposomal doxorubicin formulations in murine breast cancer. Biochim. Biophys. Acta 2004; 1663: 167–177
   PubMed Web of Science ®Google Scholar
• Eliaz R. E., Nir S., Szoka F. C. Interactions of hyaluronan-targeted liposomes with cultured cells: Modeling of binding and endocytosis. Methods Enzymol. 2004; 387: 16–33
   PubMed Web of Science ®Google Scholar
• Fields C. G., Lloyd D. H., Macdonald R. L., Otteson K. M., Noble R. L. HBTU activation for automated Fmoc solid-phase peptide synthesis. Peptide Res. 1991; 4: 95–101
   PubMedGoogle Scholar
• Gabizon A., Horowitz A. T., Goren D., Tzemach D., Mandelbaum-Shavit F., Qazen M. M., Zalipsky S. Targeting folate receptor with folate linked to extremities of poly(ethyleneglycol)-grafted liposomes: In vitro studies. Bioconj. Chem. 1999; 10: 289–298
   PubMed Web of Science ®Google Scholar
• Gabizon A. Emerging role of liposomal drug carrier systems in cancer chemotherapy. J. Liposome Res. 2003; 13: 17–20
   PubMed Web of Science ®Google Scholar
• Gabizon A., Shmeeda H., Horowitz A. T., Zalipsky S. Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid-PEG conjugates. Adv. Drug Deliv. Rev. 2004; 56: 1177–1192
   PubMed Web of Science ®Google Scholar
• Guy C. A., Fields G. B. Trifluoroacetic acid cleavage and deprotection of resin-bound peptides following synthesis by Fmoc chemistry. Methods Enzymol. 1997; 289: 67–83
   PubMed Web of Science ®Google Scholar
• Lakowicz J. R. Principles of Fluorescence Spectroscopy, 2nd ed. Kluwer Academic/Plenum Publishers, New York 1999; 54
   Google Scholar
• Longmuir K. J., Robertson R. T., Haynes S. M., Baratta J. L., Waring A. J. Effective targeting of liposomes to liver and hepatocytes in vivo by incorporation of a Plasmodium amino acid sequence. Pharm. Res. 2006; 23: 759–769
   PubMed Web of Science ®Google Scholar
• Lyon M., Deakin J. A., Gallagher J. T. Liver heparan sulfate structure. A novel molecular design. J. Biol. Chem. 1994; 269: 11208–11215
   PubMed Web of Science ®Google Scholar
• Marcucci F., Lefoulon F. F. Active targeting with particulate drug carriers in tumor therapy: Fundamentals and recent progress. Drug Discov. Today 2004; 9: 219–228
   PubMed Web of Science ®Google Scholar
• Maruyama K. PEG-immunoliposome. Biosci. Rep. 2002; 22: 251–266
   PubMed Web of Science ®Google Scholar
• Ménard R. The journey of the malaria sporozoite through its hosts: Two parasite proteins lead the way. Microbes Infect. 2000; 2: 633–642
   PubMed Web of Science ®Google Scholar
• Moghimi S. M., Szebeni J. Stealth liposomes and long circulating nanoparticles: Critical issues in pharmacokinetics, opsonization and protein-binding properties. Prog. Lipid Res. 2003; 42: 463–478
   PubMed Web of Science ®Google Scholar
• Mota M. M., Rodriguez A. Invasion of mammalian host cells by Plasmodium sporozoites. Bioessays 2002; 24: 149–156
   PubMed Web of Science ®Google Scholar
• Otera J. Esterification: Methods, Reactions, and Applications. Wiley-VCH, Weinheim 2003
   Google Scholar
• Park Y. S. Tumor-directed targeting of liposomes. Biosci. Rep. 2002; 22: 267–281
   PubMed Web of Science ®Google Scholar
• Pinzon-Ortiz C., Friedman J., Esko J., Sinnis P. The binding of the circumsporozoite protein to cell surface heparan sulfate proteoglycans is required for Plasmodium sporozoite attachment to target cells. J. Biol. Chem. 2001; 276: 26784–27791
   PubMed Web of Science ®Google Scholar
• Pradel G., Garapaty S., Frevert U. Proteoglycans mediate malaria sporozoite targeting to the liver. Mol Microbiol. 2002; 45: 637–651
   PubMed Web of Science ®Google Scholar
• Sapra P., Allen T. M. Ligand-targeted liposomal anticancer drugs. Prog. Lipid Res. 2003; 42: 439–462
   PubMed Web of Science ®Google Scholar
• Sato R., Itabashi Y., Fuhishima H., Okuyama H., Kuksis A. Simple synthesis of diastereomerically pure phosphatidylglycerols by phospholipase D-catalyzed transphosphatidylation. Lipids 2004; 39: 1025–1030
   PubMed Web of Science ®Google Scholar
• Shin S. C., Vanderberg J. P., Terzakis J. A. Direct infection of hepatocytes by sporozoites of Plasmodium berghei. J. Protozool. 1982; 29: 448–454
   PubMedGoogle Scholar
• Soroka C. J., Farquar M. G. Characterization of a novel heparan sulfate proteoglycan found in the extracellular matix of liver sinusoids and basement membranes. J. Cell Biol. 1991; 113: 1231–1241
   PubMed Web of Science ®Google Scholar
• Tewari R., Spaccepelo R., Bistoni F., Holder A. A., Crisanti A. Function of region I and II adhesive motifs of Plasmodium falciparum circumsporozoite protein in sporozoite motility and infectivity. J. Biol. Chem. 2002; 277: 47613–47618
   PubMed Web of Science ®Google Scholar
• Ungureanu E., Killick-Kendrick R., Garnham P. C., Branzie P., Romanescu C., Shute P. G. Prepatent periods of a tropical strain of Plasmodium vivax after inoculations of tenfold dilutions of sporozoites. Trans. R. Soc. Trop. Med. Hyg. 1977; 70: 482–483
   Web of Science ®Google Scholar